Motilal Oswal BSE Healthcare ETF
Category: ETFs
Launch Date: 29-07-2022
AUM:
₹ 44.4 Cr
Expense Ratio
0.36%
Benchmark
BSE Healthcare TRI
ISIN
INF247L01BB1
Minimum Investment
500.0
Minimum Topup
0.0
Minimum SIP Amount
1000
Fund Manager
Swapnil Mayekar, Dishant Mehta, Rakesh Shetty
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 9.37 | 21.79 | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
49.6368
Last change
1.1 (2.2223%)
Fund Size (AUM)
₹ 44.4 Cr
Performance
19.62% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the S&P BSE Healthcare Total Return Index, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Fund Manager
Swapnil Mayekar, Dishant Mehta, Rakesh Shetty
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 12.33 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 7.42 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.21 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 4.84 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 4.79 |
| Dr. Reddys Laboratories Ltd | 4.73 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 4.32 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 3.55 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.11 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 2.89 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.91 |
Peer Comparison
| Scheme Name | 5Y (%) |
|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.0 |